ACS chemical neuroscience molecule spotlight on Sabril

Research output: Contribution to journalShort survey

2 Citations (Scopus)

Abstract

Sabril (vigabatrin) oral solution was approved by the FDA on August 21st, 2009 for treatment of infantile spasms in children ages 1 month to 2 years and complex partial seizures in adults (tablets).

Original languageEnglish (US)
Number of pages1
JournalACS Chemical Neuroscience
Volume1
Issue number7
DOIs
StatePublished - Jul 21 2010

Fingerprint

Vigabatrin
Neurosciences
Infantile Spasms
Molecules
Tablets
Seizures
Therapeutics

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Cognitive Neuroscience
  • Cell Biology

Cite this

ACS chemical neuroscience molecule spotlight on Sabril. / Hopkins, Corey R.

In: ACS Chemical Neuroscience, Vol. 1, No. 7, 21.07.2010.

Research output: Contribution to journalShort survey

@article{541479c2124b48dc92931f52f7419ee4,
title = "ACS chemical neuroscience molecule spotlight on Sabril",
abstract = "Sabril (vigabatrin) oral solution was approved by the FDA on August 21st, 2009 for treatment of infantile spasms in children ages 1 month to 2 years and complex partial seizures in adults (tablets).",
author = "Hopkins, {Corey R.}",
year = "2010",
month = "7",
day = "21",
doi = "10.1021/cn100025k",
language = "English (US)",
volume = "1",
journal = "ACS Chemical Neuroscience",
issn = "1948-7193",
publisher = "American Chemical Society",
number = "7",

}

TY - JOUR

T1 - ACS chemical neuroscience molecule spotlight on Sabril

AU - Hopkins, Corey R.

PY - 2010/7/21

Y1 - 2010/7/21

N2 - Sabril (vigabatrin) oral solution was approved by the FDA on August 21st, 2009 for treatment of infantile spasms in children ages 1 month to 2 years and complex partial seizures in adults (tablets).

AB - Sabril (vigabatrin) oral solution was approved by the FDA on August 21st, 2009 for treatment of infantile spasms in children ages 1 month to 2 years and complex partial seizures in adults (tablets).

UR - http://www.scopus.com/inward/record.url?scp=77954950747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954950747&partnerID=8YFLogxK

U2 - 10.1021/cn100025k

DO - 10.1021/cn100025k

M3 - Short survey

C2 - 22778839

AN - SCOPUS:77954950747

VL - 1

JO - ACS Chemical Neuroscience

JF - ACS Chemical Neuroscience

SN - 1948-7193

IS - 7

ER -